The Korea Pharmaceutical and Bio-Pharma Manufacturers Association warns that a potential 25% US tariff hike on Korean pharmaceuticals would erode price competitiveness, threaten exports, and negatively impact investment and R&D, urging swift bilateral talks to resolve trade uncertainties.
#YonhapInfomax
#KPBMA #Tariff #Pharmaceuticals #Export #PriceCompetitiveness
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=102277

The Korea Pharmaceutical and Bio-Pharma Manufacturers Association has signed an agreement to adopt Yonhap Infomax's InfoX AI video platform, aiming to enhance industry communication and operational efficiency through generative AI technology.
#YonhapInfomax #KPBMA #YonhapInfomax #InfoX #ArtificialIntelligence #VideoContentProduction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=66911

Korea Pharmaceutical and Bio-Pharma Manufacturers Association partners with Yonhap Infomax to adopt InfoX, an AI-powered video platform, aiming to enhance industry communication and operational efficiency.
#YonhapInfomax #KPBMA #YonhapInfomax #InfoX #ArtificialIntelligence #VideoContentProduction #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=66905